Underlying heart disease

n = 75 patients

Rheumatic heart disease, n (%)

31 (41.3%)

Mitral valve disease, n (%)

28 (37.3%)

Aortic valve disease, n (%)

17 (22.7%)

Mixed valvular heart disease, n (%)

14 (18.7%)

Congenital heart disease, n (%)

26 (34.7%)

Post tetrology of fallot ICR¹, n (%)

7 (9.3%)

Post ICR with RV to PA conduit, n (%)

1 (1.3%)

Post ICR with PPI², n (%)

1 (1.3%)

Tetrology of fallot, n (%)

1 (1.3%)

Ventricular septal defect, n (%)

4 (5.3%)

Bicuspid aortic valve, n (%)

4 (5.3%)

Patent ductucs arteriosus, n (%)

2 (2.7%)

Subaortic membrane, n (%)

2 (2.7%)

RSOV³ with VSD, n (%)

1 (1.3%)

Post truncus arteriosus reapir, n (%)

1 (1.3%)

Post Patent ductucs arteriosus ligation, n (%)

1 (1.3%)

Tetrology of fallot with post BT⁴ shunt, n (%)

1 (1.3%)

Prosthetic valves endocarditis, n (%)

7 (9.3%)

Mitral valve prolapsed, n (%)

5 (6.7%)

Degenerative valve disease, n (%)

2 (2.7%)

No previous known heart disease, n (%)

8 (10.7%)